Swiss National Bank Cuts Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Swiss National Bank cut its position in Henry Schein, Inc. (NASDAQ:HSIC) by 3.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 408,300 shares of the company’s stock after selling 13,100 shares during the period. Swiss National Bank’s holdings in Henry Schein were worth $30,912,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of HSIC. Aurora Investment Counsel raised its stake in Henry Schein by 0.7% in the 3rd quarter. Aurora Investment Counsel now owns 20,641 shares of the company’s stock worth $1,533,000 after acquiring an additional 140 shares during the last quarter. Arizona State Retirement System boosted its stake in Henry Schein by 0.4% during the 4th quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock worth $2,717,000 after purchasing an additional 149 shares during the last quarter. Allspring Global Investments Holdings LLC grew its holdings in shares of Henry Schein by 1.8% during the third quarter. Allspring Global Investments Holdings LLC now owns 10,798 shares of the company’s stock worth $802,000 after buying an additional 194 shares in the last quarter. Thompson Investment Management Inc. raised its position in shares of Henry Schein by 2.3% in the third quarter. Thompson Investment Management Inc. now owns 8,840 shares of the company’s stock valued at $656,000 after buying an additional 200 shares during the last quarter. Finally, Wahed Invest LLC raised its position in shares of Henry Schein by 11.3% in the third quarter. Wahed Invest LLC now owns 2,035 shares of the company’s stock valued at $151,000 after buying an additional 206 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

HSIC has been the subject of several research reports. TheStreet raised shares of Henry Schein from a “c+” rating to a “b-” rating in a research note on Monday, February 26th. SVB Leerink initiated coverage on Henry Schein in a research report on Monday, February 26th. They issued a “market perform” rating and a $78.00 price target for the company. Barrington Research lifted their price objective on Henry Schein from $90.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday. Leerink Partnrs restated a “market perform” rating on shares of Henry Schein in a report on Monday, February 26th. Finally, JPMorgan Chase & Co. raised their target price on Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 6th. One research analyst has rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $81.73.

Insider Transactions at Henry Schein

In related news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the sale, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the company’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the transaction, the chief executive officer now directly owns 73,108 shares in the company, valued at $5,430,462.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Henry Schein Stock Performance

Shares of Henry Schein stock opened at $72.76 on Thursday. The firm has a market cap of $9.35 billion, a PE ratio of 23.10, a price-to-earnings-growth ratio of 1.68 and a beta of 0.87. The company has a quick ratio of 1.00, a current ratio of 1.67 and a debt-to-equity ratio of 0.45. Henry Schein, Inc. has a 52 week low of $60.01 and a 52 week high of $82.63. The business’s fifty day simple moving average is $73.01 and its 200-day simple moving average is $72.34.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, May 7th. The company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.01 by $0.09. The company had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.21 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. Henry Schein’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.21 earnings per share. Equities analysts forecast that Henry Schein, Inc. will post 5.07 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.